Introducing our latest innovation, NIKKI!

Special pricing during the month of November.

INVESTOR RELATIONS

Fremedica Technologies Inc. is a wholly owned subsidiary of Frequency Exchange Corp. The Company markets a frequency emitter that delivers the benefits of bioresonance through a lightweight, wearable device. The Fremedica product includes a special package of frequencies that support the immune system and speed recovery from Lyme disease. Lyme is the fastest-growing vector borne illness in North America. Fremedica was established in 2016 and has enjoyed rapid growth to currently serve over 1,000 customers.

FREMEDICA

>> CLICK HERE

Board of Directors

>> Meet the Directors

PRESS RELEASES

>> CLICK HERE

Stock Info

>> CLICK HERE

Financials

>> Click Here

Our Events

>> CLICK HERE

Opportunity Brief

>> Click Here

Contact US

>> CLICK HERE

TSX.V:

FREQ.V